China News Client, Beijing, May 30 (Reporter Zhang Ni) Colorectal cancer is a common cancer in the gastrointestinal tract, and early symptoms are not obvious. The incidence and mortality of colorectal cancer in China are at the forefront of all malignant tumors.

  On the 29th, Nuohui Health and Aikang Group jointly released the 2020 "White Paper on Colorectal Cancer and Precancerous Lesions of Chinese Medical Examinations" (hereinafter referred to as "White Paper on Bowel Cancer"). Early screening and follow-up data of intestinal cancer suggest that the detection rate of intestinal abnormalities is high and should be noted.

  The White Paper on Bowel Cancer focuses on follow-up tracking and data analysis for people who passed the "Chang Weiqing" test between 2016 and 2020. The overall follow-up rate reached 99.56%, the colonoscopy compliance rate was 29.38%, and the detection rate was 43.84%. .

  According to the “White Paper on Intestinal Cancer” formed from 75,000 medical examination data, the “Medical Screening Model for Early Home Cancer Screening” increases the colonoscopy compliance rate of people with high risk of bowel cancer to 29.38%. Compared with the previous data on colonoscopy compliance rate of the National Urban Cancer Early Diagnosis and Early Treatment Project, it has increased by more than 2 times.

  According to the data of "White Paper on Bowel Cancer", the number of people who tested positive accounted for 9.01%, and the follow-up for positive people accounted for an increase of 23.17% compared with the same period last year.

  During the follow-up process, 1982 people went to the hospital for further examination and / or pathological diagnosis through enteroscopy. Among them, 869 people found intestinal abnormalities, and the detection rate was 43.84%. It is worth noting that in 869 cases of intestinal abnormalities, polyps or adenoma and other early precancerous lesions accounted for up to 73%.

  The "White Paper on Bowel Cancer" also analyzes that rectal tumors (anal and digital rectal examination), increased carcinoembryonic antigen (carcinoembryonic antigen quantification (CEA) and TM12, etc.), and carbohydrate antigen 19-9 (cancer antigen 19 9 (CA19-9), TM12, etc.) and fecal erythrocyte positive (conventional stool) were detected in the colorectal cancer group that had been diagnosed were 14.29%, 37.50%, 41.67%, and 33.33%, respectively.

  The National Cancer Center has conducted urban cancer early diagnosis and early treatment projects in 22 cities in 16 provinces across the country. Its colonoscopy compliance rate for high-risk colorectal cancer screening is 14%.

  Among these people, those who have passed colonoscopy have a detection rate of 15.82% for colorectal cancer, adenoma, and polyps. Among the "Chang Weiqing" positive people, those who had passed the colonoscopy had a detection rate of 33.80% for colorectal cancer, adenoma, and polyps.

  Zhao Ping, chairman of the Professional Committee for Cancer Prevention and Control of the Chinese Preventive Medicine Association, said that among all the early diagnosis and treatment of malignant tumors, the rate of early diagnosis of colorectal cancer is the highest, reaching more than 90%.

  Industry experts said that prevention and early screening can effectively prevent cancer and improve survival rate, especially for intestinal cancer, should focus on promoting early screening of cancer. (Finish)